Tamotex (Tamoxifen) - 20mg/tab, 50 pills/bag - Euro-Pharmacies - USA

Tamoxifen (Nolvadex)

Overview: Initially developed by Astra Zeneca, Tamoxifen has been a cornerstone in treating female breast cancer and infertility. Over the years, it has gained popularity for various off-label uses and is now a leading choice for male breast cancer treatment, while still being widely utilized in women for similar indications.

Administration Method: Nolvadex is conveniently taken orally.

Classification: Secretive Estrogen Receptor Modulator (S.E.R.M).

Primary Use: The primary application of Nolvadex is in preventing and treating gynecomastia and facilitating post-cycle therapy (PCT). As an effective anti-estrogen, Nolvadex acts as the first line of defense for individuals already experiencing gynecomastia symptoms. With a stronger binding affinity to estrogen receptors in breast tissue, it immediately halts the progression of symptoms. Once symptoms are controlled, an anti-estrogen can be introduced to maintain relief. In PCT, Nolvadex serves similarly to Clomid, effectively elevating testosterone levels and restoring sperm count and motility.

Anabolic-Androgenic Ratio: N/A.

Aromatizable: No, it exhibits anti-estrogenic properties.

Progestagenic Activity: No.

Methylated: No.

Standard Dosing Guidelines and Cycle Duration: For gynecomastia prevention and treatment, Nolvadex is typically dosed at 10-20 mg per day for as long as symptoms persist. For PCT, the standard dosage ranges from 20-40 mg per day over a period of 4-6 weeks.

Administration Frequency: Daily use is recommended, taken in a single daily dose.